Zhang Yi-Liang, Guo Ying-Jun, Sun Shu-Han
Department of Medical Genetics, Second Military Medical University, 800 Xiang'Yin Road, 200433 Shanghai, China.
J Hepatol. 2009 Jul;51(1):29-38. doi: 10.1016/j.jhep.2009.03.012. Epub 2009 Apr 17.
BACKGROUND/AIMS: Innate immune responses to HCV infection are triggered through host recognition of pathogen-associated molecular patterns. Interferons are critical for the protection against HCV infection. However, the pathways linking virus recognition to IFN induction remain poorly understood.
Immune cells and Huh-7 cells were infected with HCV cell culture (HCVcc) or transfected with HCV-derived immunostimulatory RNA oligonucleotides (ORNs), and immune activation was assessed.
We found that HCVcc suppressed immune responses because the HCVcc protein impaired the PBMC and pDC responses. However, HCVcc genomic RNA had an immunostimulatory effect. HCV encodes G/U-rich ssRNA TLR7 ligands that significantly activate innate immunity, and induced IFN-alpha production. Moreover, HCV-derived ORNs also activated IRF7 and NF-kappaB in Huh-7 cells. In particular, the HCV 3'-UTR strongly induced cytokine production. Different lengths of polyuridine tract in the 3'-UTR of different HCV strains induced IFN-alpha production. These data demonstrate that the HCV-specific G/U fragment is a motif sequence, and is recognized by TLR7 as a PAMP. The requirement for TLR7 to recognize HCV RNA was confirmed using specific inhibitors, RNAi and by TLR7overexpression.
These results provide an insight into the development of immune adjuvant for vaccines and for the production of new antiviral drugs.
背景/目的:宿主对病原体相关分子模式的识别可触发对丙型肝炎病毒(HCV)感染的固有免疫反应。干扰素对于预防HCV感染至关重要。然而,将病毒识别与干扰素诱导联系起来的途径仍知之甚少。
用HCV细胞培养物(HCVcc)感染免疫细胞和Huh-7细胞,或用HCV衍生的免疫刺激RNA寡核苷酸(ORN)转染,然后评估免疫激活情况。
我们发现HCVcc抑制免疫反应,因为HCVcc蛋白损害了PBMC和pDC反应。然而,HCVcc基因组RNA具有免疫刺激作用。HCV编码富含G/U的单链RNA TLR7配体,可显著激活固有免疫,并诱导IFN-α产生。此外,HCV衍生的ORN也可在Huh-7细胞中激活IRF7和NF-κB。特别是,HCV 3'-UTR强烈诱导细胞因子产生。不同HCV毒株3'-UTR中不同长度的聚尿苷序列可诱导IFN-α产生。这些数据表明,HCV特异性G/U片段是一个基序序列,可被TLR7识别为病原体相关分子模式。使用特异性抑制剂、RNA干扰和TLR7过表达证实了TLR7识别HCV RNA的必要性。
这些结果为疫苗免疫佐剂的开发和新型抗病毒药物的生产提供了思路。